Regencell Bioscience Holdings Ltd
RGC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.8B
Close$
$0.03
99.6% downside
Current Fair Value
99.6% downsideOvervalued by 99.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.80 Billion |
|---|---|
| Enterprise Value | $3.79 Billion |
| Earnings per Share | $-0.02 |
| Beta | 1.43 |
| Outstanding Shares | 494,698,815 |
Return
| Return on Equity | -114.51% |
|---|---|
| Return on Assets | -103.78% |
| Return on Invested Capital | -114.17% |
Valuation & Multiples
| P/E Ratio | -325 |
|---|---|
| PEG | -120.87 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -247.54 |
| Enterprise Value to Net Income | -248 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
June 15, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 408.03% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.28% |
|---|---|
| Total Invested | $62▼ 100.00% |
| Investors Holding | 1▼ 40.00% |